{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:41:37Z","timestamp":1792215697699,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.metop.2026.100488","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:13:12Z","timestamp":1785708792000},"page":"100488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Empagliflozin inhibits the apoptosis of pancreatic \u03b2-cells through amelioration of endoplasmic reticulum (ER) stress"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-693X","authenticated-orcid":false,"given":"Narjes","family":"Nasiri-Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpal S.","family":"Randeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2915-6386","authenticated-orcid":false,"given":"Christina-Maria","family":"Flessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-3439","authenticated-orcid":false,"given":"Ioannis","family":"Kyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Lembessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hippokratis","family":"Kiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleni","family":"Chondrogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-388X","authenticated-orcid":false,"given":"Maria","family":"Dalamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Papavassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal S.","family":"Randeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2026.100488_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fendo.2013.00037","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metop.2026.100488_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3810\/pgm.2012.11.2615","article-title":"Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae","volume":"124","author":"Campos","year":"2012","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.metop.2026.100488_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105303","article-title":"Mechanisms of beta-cell apoptosis in type 2 diabetes-prone situations and potential protection by GLP-1-Based therapies","volume":"22","author":"Costes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2026.100488_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mam.2014.12.002","article-title":"Natural history of beta-cell adaptation and failure in type 2 diabetes","volume":"42","author":"Alejandro","year":"2015","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.metop.2026.100488_bib5","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.bpj.2020.04.005","article-title":"Beta cells operate collectively to help maintain glucose homeostasis","volume":"118","author":"Podobnik","year":"2020","journal-title":"Biophys J"},{"key":"10.1016\/j.metop.2026.100488_bib6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jcb.30247","article-title":"Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD\/MAFLD)","volume":"123","author":"Flessa","year":"2022","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metop.2026.100488_bib7","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.metop.2026.100488_bib8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4161\/cbt.5.7.2967","article-title":"The PERK\/eIF2alpha\/ATF4 module of the UPR in hypoxia resistance and tumor growth","volume":"5","author":"Fels","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.metop.2026.100488_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.metop.2026.100488_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1097-2765(00)80330-5","article-title":"Perk is essential for translational regulation and cell survival during the unfolded protein response","volume":"5","author":"Harding","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.metop.2026.100488_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/35014014","article-title":"Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response","volume":"2","author":"Bertolotti","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metop.2026.100488_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","article-title":"ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals","volume":"3","author":"Shen","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.metop.2026.100488_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13679-021-00431-3","article-title":"Endoplasmic Reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives","volume":"10","author":"Flessa","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.metop.2026.100488_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109526","article-title":"The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: an update","volume":"120","author":"Yaribeygi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metop.2026.100488_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-023-03586-1","article-title":"The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review","volume":"80","author":"Zachou","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.metop.2026.100488_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin Attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet Fed ApoE((-\/-)) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2026.100488_bib17","article-title":"The effects of empagliflozin, an SGLT2 inhibitor, on pancreatic beta-cell mass and glucose homeostasis in type 1 diabetes","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.metop.2026.100488_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94896-w","article-title":"Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic beta cells in diabetic db\/db mice","volume":"11","author":"Fushimi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.metop.2026.100488_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.11613\/BM.2013.033","article-title":"Diabetes and beta cell function: from mechanisms to evaluation and clinical implications","volume":"23","author":"Cernea","year":"2013","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.metop.2026.100488_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metop.2026.100488_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40262-013-0126-x","article-title":"Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"53","author":"Scheen","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metop.2026.100488_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010053","article-title":"Orexin-A exerts equivocal role in atherosclerosis process depending on the duration of exposure: in vitro Study","volume":"12","author":"Nasiri Ansari","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.metop.2026.100488_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810960","article-title":"Estrogen receptor subtypes elicit a distinct gene expression profile of endothelial-derived factors implicated in atherosclerotic plaque vulnerability","volume":"23","author":"Nasiri-Ansari","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2026.100488_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: recent advances in knowledge and technologies to understand disease pathogenesis","volume":"6","author":"Chen","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.metop.2026.100488_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/diabetes.50.6.1290","article-title":"High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program","volume":"50","author":"Federici","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib26","first-page":"162","article-title":"Apoptosis in pancreatic beta-islet cells in Type 2 diabetes","volume":"16","author":"Tomita","year":"2016","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.metop.2026.100488_bib27","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/db07-0178","article-title":"Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis","volume":"56","author":"Casas","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/db10-0522","article-title":"beta-cell dysfunctional ERAD\/ubiquitin\/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency","volume":"60","author":"Costes","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/cdd.2010.111","article-title":"Human-IAPP disrupts the autophagy\/lysosomal pathway in pancreatic beta-cells: protective role of p62-positive cytoplasmic inclusions","volume":"18","author":"Rivera","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.metop.2026.100488_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.08.003","article-title":"The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions","volume":"364","author":"Bensellam","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metop.2026.100488_bib31","article-title":"Correction: proteasome dysfunction mediates high glucose-induced apoptosis in rodent Beta cells and human islets","volume":"9","author":"Broca","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metop.2026.100488_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metop.2026.100488_bib33","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib34","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.2337\/db13-1383","article-title":"RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate","volume":"63","author":"Cnop","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12864-020-07003-0","article-title":"Combined transcriptome and proteome profiling of the pancreatic beta-cell response to palmitate unveils key pathways of beta-cell lipotoxicity","volume":"21","author":"Lytrivi","year":"2020","journal-title":"BMC Genom"},{"key":"10.1016\/j.metop.2026.100488_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.88","article-title":"The proapoptotic BH3-only proteins bim and puma are downstream of endoplasmic reticulum and mitochondrial oxidative stress in pancreatic islets in response to glucotoxicity","volume":"5","author":"Wali","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metop.2026.100488_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101071","article-title":"SGLT2 is not expressed in pancreatic alpha- and beta-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans","volume":"42","author":"Chae","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.metop.2026.100488_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.114.213454","article-title":"The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves beta-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat","volume":"350","author":"Hansen","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.metop.2026.100488_bib39","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1080\/21655979.2021.2001240","article-title":"Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3\/caspase-1\/GSDMD pathway in pancreatic beta cells: in vitro and in vivo studies","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.metop.2026.100488_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2813489","article-title":"Early treatment with empagliflozin and GABA improves beta-cell mass and glucose tolerance in Streptozotocin-Treated mice","volume":"2019","author":"Daems","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metop.2026.100488_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2015.10.109","article-title":"Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in obese type 2 diabetic db\/db mice","volume":"470","author":"Okauchi","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metop.2026.100488_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jdi.12945","article-title":"Early administration of dapagliflozin preserves pancreatic beta-cell mass through a legacy effect in a mouse model of type 2 diabetes","volume":"10","author":"Kanno","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.metop.2026.100488_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00210-023-02607-1","article-title":"Empagliflozin reduces endoplasmic reticulum stress associated TXNIP\/NLRP3 activation in tunicamycin-stimulated aortic endothelial cells","volume":"397","author":"Campeau","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.metop.2026.100488_bib44","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/ajt.14316","article-title":"Effect of empagliflozin on tacrolimus-induced pancreas islet dysfunction and renal injury","volume":"17","author":"Jin","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.metop.2026.100488_bib45","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/jc.2017-01838","article-title":"Empagliflozin treatment is associated with improved beta-cell function in type 2 diabetes mellitus","volume":"103","author":"Al Jobori","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metop.2026.100488_bib46","doi-asserted-by":"crossref","DOI":"10.2337\/db18-1187-P","article-title":"Effects of SGLT2 inhibitors on insulin secretion and insulin Resistance\u2014results from a cross-sectional study","volume":"67","author":"Waseda","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2026.100488_bib47","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.1038\/s41598-025-93144-9","article-title":"Single cell transcriptomic analysis of SGLT2 expression supports an indirect or off-target role for the cardioprotective benefits of empagliflozin in heart failure","volume":"15","author":"Mourad","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metop.2026.100488_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258054","article-title":"SGLT2 inhibitors therapy protects glucotoxicity-induced beta-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress","volume":"17","author":"Shyr","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.metop.2026.100488_bib49","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1074\/jbc.M110.216093","article-title":"Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation","volume":"286","author":"Palam","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metop.2026.100488_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","article-title":"An integrated stress response regulates amino acid metabolism and resistance to oxidative stress","volume":"11","author":"Harding","year":"2003","journal-title":"Mol Cell"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:43:55Z","timestamp":1788626635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936826000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S2589936826000472"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100488","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin inhibits the apoptosis of pancreatic \u03b2-cells through amelioration of endoplasmic reticulum (ER) stress","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100488"}}